View the NDEWS Weekly Briefing Issue 274 ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­ ͏ ‌     ­
webversion | unsubscribe | update profile
 
Issue 274: March 13, 2026
 
new briefing header (1)
 

This Week’s Focus: Synthetic Cannabinoids

This issue of the NDEWS Weekly Briefing focuses on synthetic cannabinoids (SCs), a diverse group of lab synthesized chemicals applied to dried plant material or sold as concentrated liquids for use in vaporizers. These substances have repeatedly appeared in discussions within our NDEWS network.

The US Drug Enforcement Administration first detected synthetic cannabinoids inside the US in products like “Spice” and "K2" in 2008, and since then their chemical diversity has expanded rapidly. Despite federal and state scheduling efforts, new variants continue to emerge and make their way to gas stations, smoke shops, and online retailers with labeling claiming the products are "not for human consumption."

Only three synthetic cannabis-related drug products are currently approved by the US Food & Drug Administration and each of the three (Marinol, Syndros, Cesamet) requires a prescription for use.

Up‑to‑date insights from the NDEWS network come together here in the form of our latest NDEWS Special Report and Web Monitoring Report to outline synthetic cannabinoid activity observed during the reporting window.

As always, we welcome your input.
 
 

NDEWS ORIGINAL CONTENT

 
 

NDEWS Special Report: Top 10 US counties per region with the highest rates of EMS encounters involving nonfatal synthetic cannabinoid overdoses per 10,000 population

 
top-10-us-counties-per-region-with-the-highest-rates-of-ems-encounters-involving-nonfatal-synthetic-cannabinoid-overdoses
 
Nationally, 19,688 nonfatal EMS encounters involving synthetic cannabinoid overdoses were reported from January 1, 2023 to February 28, 2026. Of these, 2,280 (11.6%) occurred in Western states, 1,380 (7.0%) in Midwestern states, 8,890 (45.2%) in Southern states, and 7,138 (36.3%) in Northeastern states. Counties with ≥ 10 encounters are presented above as encounters per 10,000 population; counties with fewer than 10 encounters have been suppressed. To view the entire Special Report from the weekly briefing, click here.
Click here to learn more about NDEWS Hotspot Alerts
 
share your thoughts-01
twitter button-01

 

NDEWS Web Monitoring Report: Synthetic Cannabinoids

 
2026-03-13_sum_of_synthetic_cannabinoid_reddit_posts_unique_users_rolling_30-day_window
 

Why are we reporting on this? Synthetic cannabinoids (SCs), frequently referred to by names such as "K2", "Spice", or "Mojo", are a recurring topic of concern on Reddit due to significant health risks and addictive potential. Reddit discussions reveal emerging patterns including reports of sudden seizures, severe cardiovascular distress, and acute psychosis triggered by products often marketed as legal alternatives to cannabis. Reports from family members describe significant behavioral shifts and interpersonal challenges occurring during periods of dependency or withdrawal. Additionally, there is an ongoing community discussion regarding the term “marijuana,” with many discussants suggesting that this terminology may inaccurately characterize the distinct toxicology and risk profile associated with synthetic cannabinoid compounds.

What are Synthetic Cannabinoids? SCs are a diverse group of lab synthesized chemicals applied to dried plant material or sold as concentrated liquids for use in vaporizers. Commercial products containing these substances are commonly found at gas stations, smoke shops, and online retailers, often bearing labels claiming they are not intended for human consumption to bypass legal regulations.

Public Health Impacts: Reddit discussants report significant and life-threatening adverse effects from SC consumption, including grand mal seizures, tachycardia, and acute psychosis. Multiple commenters describe experiencing severe physical reactions such as high fevers and intense nausea, while also noting a dangerous nodding cycle where individuals lose consciousness and immediately resume administration upon waking. Discussants mention long-term cognitive challenges, such as "memory holes" and decreased verbal fluency, that persist for months or years after cessation. Reports also describe a specific looping phenomenon where individuals feel trapped in brief time loops and a state of agitated delirium that has been linked to acts of severe self-harm or violence.

How is it Being Discussed? Reddit commenters discuss SCs across several distinct themes, frequently noting that modern formulas are significantly more toxic than 2010 era versions. Conversations regarding "Spice" often focus on the discovery of these chemicals in unregulated vapes, while "K2" is associated with accidental consumption through laced products and prison culture. When using the term synthetic marijuana, discussants often debate whether the name itself is a misleading "dangerous false sense of safety," while SCs appear in technical trip reports describing a "Groundhog Day" looping phenomenon and the loss of full body control from sophisticated "c-liquids." Discussions of herbal incense frequently reference specific branding and chemical odors reminiscent of bug spray, and herbal smoking blends are discussed as stealth headshop products used to produce a dissociative high. "Mojo" is defined by discussants as a poison or dangerous chemical cocktail linked to grand mal seizures and agitated delirium, with emerging concerns regarding its use as an adulterant in low-quality natural cannabis flower. Individuals across all terms share strategies for drug test evasion in high stakes employment and seek advice on using complex supplement stacks to recover from perceived neurological damage. These substances are frequently mentioned alongside the co-use of fentanyl, methamphetamine, and other research chemicals.

Because of the number of terms searched and used to generate this report, our team thought it necessary to include a methodological note to ensure clarity and transparency:

Methodological Note: Data for this analysis were collected using the Reddit API from a curated set of more than 100 subreddits associated with substance use, pharmacology, and harm reduction. To capture discussion related to SCs, the query incorporated multiple terms including the clinical designation “synthetic cannabinoids,” widely used street names such as “K2,” “Spice,” and “Mojo,” and common descriptors including “herbal incense” and “synthetic marijuana.” The metric Total Posts reflects the number of submissions containing at least one of the target keywords and serves as a proxy for overall discussion volume surrounding these substances. Unique Visitors represents the number of distinct accounts contributing to these posts, allowing differentiation between spikes driven by broad community participation versus activity concentrated among a smaller group of highly active visitors. To reduce the influence of short-term fluctuations in social media activity, a 30-day rolling sum was applied, smoothing daily volatility and highlighting more sustained trends in discussion. Because posts may contain multiple keywords (e.g., both “K2” and “Spice”), all results were deduplicated by unique Reddit post ID to ensure that individual discussion threads were counted only once.

 
share your thoughts-01
twitter button-01

 

PUBLICATIONS

 
 

Identification and structural elucidation of a new synthetic cannabinoid, MDMB-5'Br-PINACA, in seized herbal materials

 
3-6-26_molecular-structure-of-mdmb-5%e2%80%b2br-pinaca
 
A recently published study in Drug Testing and Analysis by Barcia de Godoi et al. reported on the discovery and structural elucidation of MDMB-5′Br-PINACA. This previously unreported synthetic cannabinoid (SC) was identified in three seized herbal materials obtained between May 2024 and July 2024 in the city of Jundiaí, Sao Paulo, Brazil. Additionally, other SCs were detected in the analyzed materials, such as 5F-ADB and MDMB-4en-PINACA, and it also included the synthetic precursor MDMB-INACA. The authors emphasized the importance of continuous monitoring and early detection of emerging substances. Read the full study here.
 
share your thoughts-01
twitter button-01

 

Data hidden in sewage: Advanced methods for identification and quantification of synthetic cannabinoids in urban wastewater

 
3-6-26_challenges-associated-with-the-analysis-of-synthetic-cannabinoids-in-wastewater-at-each-experimental-stage-created-in-biorender
 
A recently published study in Molecules by Kurzeja et al. summarized the available literature published between 2013 and 2025 on the detection and quantification of synthetic cannabinoids (SCs) in raw wastewater samples. The authors determined that the reviewed studies show that wastewater analysis reflected the dynamic evolution of the SCs market. The authors concluded that future studies should address further stability tests, investigation of the metabolism of SCs, and careful selection of the effective SCs extraction method from the complex environmental matrix. Read the full study here.
 
share your thoughts-01
twitter button-01

 

Neurotoxic potential of synthetic cannabinoids' pyrolysis products

 
3-6-26_structural-elements-of-synthetic-cannabinoids_examples-of-common-groups-present-in-synthetic-cannabinoid-structures
 
A recently published study in Toxicology by Pita et al. addressed the neurotoxicity associated with parent synthetic cannabinoid (SC) compounds and their pyrolysis products. A PRISMA-guided systematic review identified only nine studies specifically investigating the neurotoxic effects of SC pyrolysis products, revealing a significant gap in the literature and underscoring the urgent need for research. The authors noted that future research should prioritize the identification and characterization of pyrolysis-derived toxicants, the advancement of analytical methodologies for their detection and the implementation of evidence-based public health strategies. Read the full study here.
 
share your thoughts-01
twitter button-01

 

NEWS & REPORTS

 
 

CFSRE Trend Report: Synthetic cannabinoids in the United States - Q4 2025

 
4-4-25_cfsre_logo
 
The Center for Forensic Science Research & Education recently published the latest trend report regarding the status of synthetic cannabinoids in the US. Read the full trend report here.
 
share your thoughts-01
twitter button-01

 

NYC Health Advisory: Increases in synthetic cannabinoid (K2)-related emergency department visits in NYC

 
nyc-health
 
The New Your City Department of Health and Mental Hygiene published a report on October 6, 2025, concerning the increase of synthetic cannabinoid-related emergency department visits. The advisory noted that there were at lease nine unintentional drug overdose deaths that involved synthetic cannabinoids and no other substances, which was an increase from at least two deaths during the entirety of 2024.  Read the full advisory here.
 
share your thoughts-01
twitter button-01

 

NDEWS OPPORTUNITIES

 
 

Join the UF T32 Training Program in Substance Abuse and Public Health as a Pre or Postdoc! Work with the NDEWS Team!

 
2025-nida-t32-postcard
 

Are you committed to advancing the science of substance use and public health? The University of Florida’s NIDA-funded T32 Training Program offers predoctoral and postdoctoral scholars an exceptional opportunity to launch impactful research careers focused on NDEWS!

What We Offer:
- Interdisciplinary training at the intersection of addiction science, epidemiology, and surveillance
- Mentorship from leading UF faculty in epidemiology, public health, psychology, medicine, and more
- Hands-on research with landmark and important NIH-funded projects and access to rich data
- Career development support, including grant writing, publishing, and professional networking
- A collaborative, inclusive research community committed to reducing the burden of substance use

Eligibility:
- US citizens or permanent residents
- Interested in a PhD in Epidemiology, or early-stage postdoctoral fellows
- Demonstrated interest in substance use, addiction, or public health research

Location: Gainesville, Florida — a dynamic hub for scientific innovation with high quality of life and low cost of living.
 
 
Click Here To Apply
 

 

UPCOMING WEBINARS & EVENTS

 
ocoh_march_2026
 

Our Community, Our Health - NDEWS Webinar: State of Crime and Fraud in the GLP-1 Space

 
 

Shabbir Imber Safdar, CFE is the Executive Director of the Partnership for Safe Medicines, a coalition of members of the drug supply chain focused on the danger of counterfeit and unsafe medicines. Shabbir will present the broad threat to patients of medical fraud in the GLP-1 space, including: lookalike counterfeits, unapproved substances, illegal sales on social media, illegal transnational diversion, and unsafe and illegal compounding.

📅 Date: Thursday, March 19, 2026

🕑 Time: 2:00 pm - 3:00 pm ET

📍 Location: Online - Register Here
 
share your thoughts-01
twitter button-01

2026_portland_cpdd-1
 

NDEWS Summit at CPDD

 
 

📅 Date: Saturday, June 13, 2026

🕑 Time: 1:00 pm - 5:00 pm PT

📍 Location: Oregon Convention Center & Hyatt Regency Portland
 
share your thoughts-01
twitter button-01

 

ABOUT NDEWS

 
 

The NDEWS Weekly Briefing curates emerging data and findings from across the Early Warning Network, which includes three core components: our Scientific Advisory Group (SAG), comprised of national experts and federal partners; our Sentinel Site Directors (SSDs), who lead local surveillance in key geographic regions; and our Community-Based Health Experts, who provide on-the-ground insights from populations most impacted by drug trends. Together, these contributors generate timely, multidisciplinary and impactful information, ranging from peer-reviewed research findings to local surveillance data. These contributions inform public health and research communities.
 
 

Help Support Our Work!
 
screenshot-2024-08-30-013133
 

You can share the NDEWS Weekly Briefing with friends, colleagues, and others who would benefit from information on recent and relevant news, articles, and data related to novel drug trends in the US and globally by clicking here.
 
screenshot-2024-08-30-020640
NDEWS Submission Form Graphic (6)
 

Get in Touch with NDEWS

Share your research, news, and events through our submission form.
Share your comments on our newsletter through our feedback form.
For more information on NDEWS' efforts, visit our website.
Follow NDEWS on Twitter/X: @NDEWSnews
If you miss or want to learn more about NDEWS Original Content, you can find our archived content on the NDEWS website:
     • NDEWS Hotspot Alerts using substance-related EMS data
     • NDEWS Rapid Street Reporting (RSR) survey data reports
     • NDEWS Web Monitoring Team Reddit Alerts
     • NDEWS Sentinel Site Reports
     • Previous issues of the NDEWS Weekly Briefings
 
email_footer-2-2
 

The Weekly Briefing is a newsletter published each week by the National Drug Early Warning System (NDEWS) Coordinating Center, which is funded by the National Institute on Drug Abuse (U01DA051126) to the University of Florida (MPI: Cottler (contact), Co-Is: Goldberger, Nixon, Striley), NYU Langone Health (MPI: Palamar), and Florida Atlantic University (Co-I: Barenholtz). Any item may be reproduced provided the source is acknowledged.
 
 
Copyright © 2025 National Drug Early Warning System (NDEWS), All rights reserved.